BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21896028)

  • 1. B19: benign or not?
    Dodd RY
    Transfusion; 2011 Sep; 51(9):1878-9. PubMed ID: 21896028
    [No Abstract]   [Full Text] [Related]  

  • 2. [An exceptional cause of acute hepatitis in an adult: parvovirus B19].
    Martínez González J; Senosiain Lalastra C; Mesonero Gismero F; Moreira Vicente V
    Gastroenterol Hepatol; 2012 Dec; 35(10):697-9. PubMed ID: 22749503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
    Cassinotti P; Burtonboy G; Fopp M; Siegl G
    J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complexity in interpreting partial viral sequence data as supportive evidence for possible transfusion transmitted Parvovirus B19 infection.
    Chan HT
    Vox Sang; 2016 Apr; 110(3):295. PubMed ID: 26646810
    [No Abstract]   [Full Text] [Related]  

  • 5. [Detection of parvovirus B19 markers in blood samples of donors].
    Filatova EV; Zubkova NV; Novikova NA; Golitsina LN; Kuznetsov KV
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (5):67-70. PubMed ID: 21061580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of a study of parvovirus B19 (Parvoviridae, Parvovirinae, Erythroparvovirus, Primate erythroparvovirus 1) prevalence and circulation activity in socially significant categories of the population].
    Nikishov ON; Kuzin AA; Zobov AE; Lavrentieva IN; Antipova AY; Ostankova YV; Khamitova IV; Nikishov SN
    Vopr Virusol; 2020 Jul; 65(3):143-149. PubMed ID: 33533216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parvovirus B19-induced type II mixed cryoglobulinemia.
    Gorse A; Boileau J; Goetz J; Stoll-Keller F; Martin T
    Am J Med; 2011 Sep; 124(9):e7-8. PubMed ID: 21854885
    [No Abstract]   [Full Text] [Related]  

  • 8. Presence and significance of parvovirus B19 in blood and blood products.
    Siegl G; Cassinotti P
    Biologicals; 1998 Jun; 26(2):89-94. PubMed ID: 9811511
    [No Abstract]   [Full Text] [Related]  

  • 9. [Parvovirus B19. Position of the Blood Working Group of the Federal Ministry of Health].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):944-56. PubMed ID: 20853092
    [No Abstract]   [Full Text] [Related]  

  • 10. High prevalence of parvovirus B19 infection in patients with chronic kidney disease under hemodialysis: A multicenter study.
    Alves ADR; Langella BB; Barbosa JR; Lima DM; Colares JKB; Garcia RCNC; Pinto MA; Villar LM; Amado LA
    Int J Infect Dis; 2020 Nov; 100():350-356. PubMed ID: 32927082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human parvovirus B19: prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients.
    Jordan J; Tiangco B; Kiss J; Koch W
    Vox Sang; 1998; 75(2):97-102. PubMed ID: 9784661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic parvovirus B19 infection caused by blood component transfusion.
    Satake M; Hoshi Y; Taira R; Momose SY; Hino S; Tadokoro K
    Transfusion; 2011 Sep; 51(9):1887-95. PubMed ID: 21332725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of multiple-unit transfusions.
    Tankersley DL
    Vox Sang; 2000; 78(2):132. PubMed ID: 10765153
    [No Abstract]   [Full Text] [Related]  

  • 14. The prevalence and persistence of human parvovirus B19 infection in thalassemic patients.
    Siritantikorn S; Kaewrawang S; Siritanaratkul N; Theamboonlers A; Poovorawan Y; Kantakamalakul W; Wasi C
    Asian Pac J Allergy Immunol; 2007; 25(2-3):169-74. PubMed ID: 18035805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Parvovirus B19 among blood donors from three hospitals in Santiago, Chile].
    Lévican J; Torres M; Gaggero N; Corvalán R; Gaggero A
    Rev Med Chil; 2011 Feb; 139(2):143-9. PubMed ID: 21773649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of parvovirus B 19 infection in children with aplastic anemia.
    Gupta V; Saini I; Nath G
    Indian Pediatr; 2013 May; 50(5):489-91. PubMed ID: 23255678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Look-back study on recipients of Parvovirus B19 (B19V) DNA-positive blood components.
    Juhl D; Özdemir M; Dreier J; Görg S; Hennig H
    Vox Sang; 2015 Nov; 109(4):305-11. PubMed ID: 26053938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myopericarditis due to parvovirus B19 in an adult.
    Chia JK; Jackson B
    Clin Infect Dis; 1996 Jul; 23(1):200-1. PubMed ID: 8816166
    [No Abstract]   [Full Text] [Related]  

  • 19. The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers.
    Ke L; He M; Li C; Liu Y; Gao L; Yao F; Li J; Bi X; Lv Y; Wang J; Hirsch ML; Li W
    Transfusion; 2011 Sep; 51(9):1909-18. PubMed ID: 21382040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area.
    Parsyan A; Addo-Yobo E; Owusu-Ofori S; Akpene H; Sarkodie F; Allain JP
    Transfusion; 2006 Sep; 46(9):1593-600. PubMed ID: 16965589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.